Found: 6
Select item for more details and to access through your institution.
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial Designs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1132, doi. 10.1002/cpt.2869
- By:
- Publication type:
- Article
How to use prior knowledge and still give new data a chance?
- Published in:
- Pharmaceutical Statistics, 2018, v. 17, n. 4, p. 329, doi. 10.1002/pst.1862
- By:
- Publication type:
- Article
Conditional approval: discussion points from the PSI conditional approval expert group.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 263, doi. 10.1002/pst.309
- By:
- Publication type:
- Article
Assessing the impact of ICH E9.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 77, doi. 10.1002/pst.337
- By:
- Publication type:
- Article
The p-Value: Guilty by Association.
- Published in:
- Statistics in Biopharmaceutical Research, 2021, v. 13, n. 1, p. 32, doi. 10.1080/19466315.2020.1854845
- By:
- Publication type:
- Article
Under a Black Cloud Glimpsing a Silver Lining: Comment on Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.
- Published in:
- Statistics in Biopharmaceutical Research, 2020, v. 12, n. 4, p. 414, doi. 10.1080/19466315.2020.1785931
- By:
- Publication type:
- Article